Shu Wakino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shu Wakino has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Itoh
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
11 shared publications- Hirobumi Tokuyama
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications Koichi Hayashi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications- Koichi Hayashi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications Kazuhiro Hasegawa
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
4 shared publicationsKyoko Yoshioka
4 shared publications
Latest Publications
- 2 July 2018
- Published byย Oxford University Press (OUP)ย inย Clinical Infectious Diseases
- Vol.ย 67 ย (2) , 312-313
Multinuclear and Ground Glass-Formed Cells Detected in the Peritoneal Dialysate
(See pages 311โ2 for the Photo Quiz.)
- 2 July 2018
- Published byย Oxford University Press (OUP)ย inย Clinical Infectious Diseases
- Vol.ย 67 ย (2) , 312-313
Multinuclear and Ground Glass-Formed Cells Detected in the Peritoneal Dialysate
(See pages 311โ2 for the Photo Quiz.)
- 10 May 2017
- Published byย Japanese Society of Internal Medicineย inย Nihon Naika Gakkai Zasshi
- Vol.ย 106 ย (5) , 1019-1028
Aging and Chronic Kidney Disease
- 10 May 2017
- Published byย Japanese Society of Internal Medicineย inย Nihon Naika Gakkai Zasshi
- Vol.ย 106 ย (5) , 1019-1028
Aging and Chronic Kidney Disease
- Open Access
- 14 May 2016
- Published byย Oxford University Press (OUP)ย inย Nephrology Dialysis Transplantation
- Vol.ย 31 ย (suppl_1) , i474
MP402IMPROVEMENT OF PHYSICAL DECLINE THROUGH COMBINED EFFECTS OF MUSCLE ENHANCEMENT AND MITOCHONDRIAL ACTIVATION BY A GASTRIC HORMONE GHRELIN IN MALE 5/6NX CKD MODEL MICE
Introduction and Aims: Chronic kidney disease (CKD) impairs physical performance. A physical decline correlates with an increased risk of a wide range of disease and morbidity. The principal cause of physical decline has been regarded as a decrease in muscle mass. However, our recent study showed that a decrease in muscle mitochondria plays a critical role, associated with a reduction in the expression of muster regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor-ฮณ coactivator-1ฮฑ (PGC-1ฮฑ). Recently, a DNA methylation of the cytosine residue at 260 base pairs upstream (C-260) of initiation point of the PGC-1ฮฑ gene was demonstrated to significantly decrease the gene expression. Ghrelin, a gastric hormone, treatment was reported to increase muscle mass and promote muscle mitochondrial oxidation. In the present study, we examined the usefulness of ghrelin treatment for a recovery of physical decline in 5/6 nephrectomized (5/6Nx) CKD model mice, in comparison with IGF-1 treatment.
- 14 May 2016
- Published byย Oxford University Press (OUP)ย inย Nephrology Dialysis Transplantation
- Vol.ย 31 ย (suppl_1) , i474
Open AccessMP402IMPROVEMENT OF PHYSICAL DECLINE THROUGH COMBINED EFFECTS OF MUSCLE ENHANCEMENT AND MITOCHONDRIAL ACTIVATION BY A GASTRIC HORMONE GHRELIN IN MALE 5/6NX CKD MODEL MICE
Introduction and Aims: Chronic kidney disease (CKD) impairs physical performance. A physical decline correlates with an increased risk of a wide range of disease and morbidity. The principal cause of physical decline has been regarded as a decrease in muscle mass. However, our recent study showed that a decrease in muscle mitochondria plays a critical role, associated with a reduction in the expression of muster regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor-ฮณ coactivator-1ฮฑ (PGC-1ฮฑ). Recently, a DNA methylation of the cytosine residue at 260 base pairs upstream (C-260) of initiation point of the PGC-1ฮฑ gene was demonstrated to significantly decrease the gene expression. Ghrelin, a gastric hormone, treatment was reported to increase muscle mass and promote muscle mitochondrial oxidation. In the present study, we examined the usefulness of ghrelin treatment for a recovery of physical decline in 5/6 nephrectomized (5/6Nx) CKD model mice, in comparison with IGF-1 treatment.
- 1 November 2015
- Published byย Elsevierย inย Journal of Clinical Lipidology
- Vol.ย 9 ย (6) , 751-757
Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions
- 1 November 2015
- Published byย Elsevierย inย Journal of Clinical Lipidology
- Vol.ย 9 ย (6) , 751-757
Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions
- 1 March 2015
- Published byย Elsevierย inย Journal of Clinical Lipidology
- Vol.ย 9 ย (2) , 210-216
Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin
- 1 March 2015
- Published byย Elsevierย inย Journal of Clinical Lipidology
- Vol.ย 9 ย (2) , 210-216
Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin
- Top Cited PapersOpen Access
- 20 October 2013
- Published byย Springer Natureย inย Nature Medicine
- Vol.ย 19 ย (11) , 1496-1504
Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
Diabetic nephropathy is the most common cause of end-stage renal disease. Shu Wakino and colleagues now show that high-glucose conditions in the renal proximal tubules result in downregulation of Sirt1 expression there and in the glomeruli, resulting in epigentic upregulation of Claudin-1 in the glomeruli and thus proteinuria. They also show that genetic or chemical targeting of Sirt1 in the kidney is sufficient to improve kidney function in a mouse model of diabetic nephropathy. Sirtuin 1 (Sirt1), a NAD+-regulated deacetylase with numerous known positive effects on cellular and whole-body metabolism, is expressed in the renal cortex and medulla. It is known to have protective effects against age-related disease, including diabetes. Here we investigated the protective role of Sirt1 in diabetic renal damage. We found that Sirt1 in proximal tubules (PTs) was downregulated before albuminuria occurred in streptozotocin-induced or obese (db/db) diabetic mice. PT-specific SIRT1 transgenic and Sirt1 knockout mice showed prevention and aggravation of the glomerular changes that occur in diabetes, respectively, and nondiabetic knockout mice exhibited albuminuria, suggesting that Sirt1 in PTs affects glomerular function. Downregulation of Sirt1 and upregulation of the tight junction protein Claudin-1 by SIRT1-mediated epigenetic regulation in podocytes contributed to albuminuria. We did not observe these phenomena in 5/6 nephrectomized mice. We also demonstrated retrograde interplay from PTs to glomeruli using nicotinamide mononucleotide (NMN) from conditioned medium, measurement of the autofluorescence of photoactivatable NMN and injection of fluorescence-labeled NMN. In human subjects with diabetes, the levels of SIRT1 and Claudin-1 were correlated with proteinuria levels. These results suggest that Sirt1 in PTs protects against albuminuria in diabetes by maintaining NMN concentrations around glomeruli, thus influencing podocyte function.
- 20 October 2013
- Published byย Springer Natureย inย Nature Medicine
- Vol.ย 19 ย (11) , 1496-1504
Top Cited PapersOpen AccessRenal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
Diabetic nephropathy is the most common cause of end-stage renal disease. Shu Wakino and colleagues now show that high-glucose conditions in the renal proximal tubules result in downregulation of Sirt1 expression there and in the glomeruli, resulting in epigentic upregulation of Claudin-1 in the glomeruli and thus proteinuria. They also show that genetic or chemical targeting of Sirt1 in the kidney is sufficient to improve kidney function in a mouse model of diabetic nephropathy. Sirtuin 1 (Sirt1), a NAD+-regulated deacetylase with numerous known positive effects on cellular and whole-body metabolism, is expressed in the renal cortex and medulla. It is known to have protective effects against age-related disease, including diabetes. Here we investigated the protective role of Sirt1 in diabetic renal damage. We found that Sirt1 in proximal tubules (PTs) was downregulated before albuminuria occurred in streptozotocin-induced or obese (db/db) diabetic mice. PT-specific SIRT1 transgenic and Sirt1 knockout mice showed prevention and aggravation of the glomerular changes that occur in diabetes, respectively, and nondiabetic knockout mice exhibited albuminuria, suggesting that Sirt1 in PTs affects glomerular function. Downregulation of Sirt1 and upregulation of the tight junction protein Claudin-1 by SIRT1-mediated epigenetic regulation in podocytes contributed to albuminuria. We did not observe these phenomena in 5/6 nephrectomized mice. We also demonstrated retrograde interplay from PTs to glomeruli using nicotinamide mononucleotide (NMN) from conditioned medium, measurement of the autofluorescence of photoactivatable NMN and injection of fluorescence-labeled NMN. In human subjects with diabetes, the levels of SIRT1 and Claudin-1 were correlated with proteinuria levels. These results suggest that Sirt1 in PTs protects against albuminuria in diabetes by maintaining NMN concentrations around glomeruli, thus influencing podocyte function.
- 1 April 2013
- Published byย Bioscientificaย inย Endocrine Abstracts
5/6 Nephrectomy reduces muscle mitochondria in mice as to decrease exercise endurance associated with further exacerbation by dietary protein
Introduction: Chronic kidney disease impairs physical performance from an early stage of disease, and the impairment is a critical medical problem because lowered physical activity correlates with renal prognosis and mortality, and constitutes an independent cardiovascular risk for chronic kidney disease patients, with as high an impact as hypertension and diabetes. In this study, the time course and mechanism of muscle insufficiency in renal failure were investigated using 5/6 nephrectomized (5/6Nx) mice, a model of mild chronic kidney disease. Furthermore, the effect of high-protein diet on chronic kidney disease was examined. Methods: C57bl/6 mice which had undergone 5/6 nephrectomy at 6โ7 weeks were examined for physical performance in young (16โ20 weeks old) and aged (48โ52 weeks old) groups. Protein adjusted diets were fed from 8 weeks old. Results: A decrease in muscle mitochondria and running distance was identified in young 5/6Nx mice, despite the preservation of muscle volume and power. Thereafter, a decrease in muscle volume associated with a reduction in muscle power became apparent in aged 5/6Nx mice. A high-protein diet feeding from 8 weeks old increased muscle volume and power in the mice; however, it further decreased running distance, associated with a decrease in the activity of pyruvate dehydrogenase which promotes aerobic glycolysis. Activation of pyruvate dehydrogenase by dichroloacetate effectively recovered running distance which was decreased by dietary protein. Conclusion: A decrease in muscle mitochondria was identified as a new mechanism for the reduction in exercise endurance of 5/6 nephrectomy mice. Decreased pyruvate dehydrogenase activity accounted for the further reduction in exercise endurance by dietary protein. These findings clarify the mechanism of muscle insufficiency in renal failure and suggest activation of muscle mitochondria as a potential strategy for the improvement of physical performance of patients with chronic kidney disease.
- 1 April 2013
- Published byย Bioscientificaย inย Endocrine Abstracts
5/6 Nephrectomy reduces muscle mitochondria in mice as to decrease exercise endurance associated with further exacerbation by dietary protein
Introduction: Chronic kidney disease impairs physical performance from an early stage of disease, and the impairment is a critical medical problem because lowered physical activity correlates with renal prognosis and mortality, and constitutes an independent cardiovascular risk for chronic kidney disease patients, with as high an impact as hypertension and diabetes. In this study, the time course and mechanism of muscle insufficiency in renal failure were investigated using 5/6 nephrectomized (5/6Nx) mice, a model of mild chronic kidney disease. Furthermore, the effect of high-protein diet on chronic kidney disease was examined. Methods: C57bl/6 mice which had undergone 5/6 nephrectomy at 6โ7 weeks were examined for physical performance in young (16โ20 weeks old) and aged (48โ52 weeks old) groups. Protein adjusted diets were fed from 8 weeks old. Results: A decrease in muscle mitochondria and running distance was identified in young 5/6Nx mice, despite the preservation of muscle volume and power. Thereafter, a decrease in muscle volume associated with a reduction in muscle power became apparent in aged 5/6Nx mice. A high-protein diet feeding from 8 weeks old increased muscle volume and power in the mice; however, it further decreased running distance, associated with a decrease in the activity of pyruvate dehydrogenase which promotes aerobic glycolysis. Activation of pyruvate dehydrogenase by dichroloacetate effectively recovered running distance which was decreased by dietary protein. Conclusion: A decrease in muscle mitochondria was identified as a new mechanism for the reduction in exercise endurance of 5/6 nephrectomy mice. Decreased pyruvate dehydrogenase activity accounted for the further reduction in exercise endurance by dietary protein. These findings clarify the mechanism of muscle insufficiency in renal failure and suggest activation of muscle mitochondria as a potential strategy for the improvement of physical performance of patients with chronic kidney disease.
- Open Access
- 1 June 2012
- Published byย Springer Natureย inย BMC Nephrology
- Vol.ย 13 ย (1) , 32
MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into pauci-immune RPGN, in which there are few or no immune complexes.
- 1 June 2012
- Published byย Springer Natureย inย BMC Nephrology
- Vol.ย 13 ย (1) , 32
Open AccessMPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into pauci-immune RPGN, in which there are few or no immune complexes.
- Open Access
- 20 December 2011
- Published byย Springer Natureย inย International Journal of Obesity
- Vol.ย 36 ย (8) , 1062-1071
Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury
We examined whether aldosterone/Rho/Rho-kinase pathway contributed to obesity-associated nephropathy. C57BL/6J mice were fed a high fat or low fat diet, and mice on a high fat diet were treated with a mineralocorticoid receptor antagonist, eplerenone. The mice on a high fat diet not only developed obesity, but also manifested renal histological changes, including glomerular hypercellularity and increased mesangial matrix, which paralleled the increase in albuminuria. Furthermore, enhanced Rho-kinase activity was noted in kidneys from high fat diet-fed mice, as well as increased expressions of inflammatory chemokines. All of these changes were attenuated by eplerenone. In high fat diet-fed mice, mineralocorticoid receptor protein levels in the nuclear fraction and SGK1, an effector of aldosterone, were upregulated in kidneys, although serum aldosterone levels were unaltered. Furthermore, aldosterone and 3ฮฒ-hydroxysteroid dehydrogenase in renal tissues were upregulated in high fat diet-fed mice. Finally, in cultured mesangial cells, stimulation with aldosterone enhanced Rho-kinase activity, and pre-incubation with eplerenone prevented the aldosterone-induced activation of Rho kinase. Excess fat intake causes obesity and renal injury in C57BL/6J mice, and these changes are mediated by an enhanced mineralocorticoid receptor/Rho/Rho-kinase pathway and inflammatory process. Mineralocorticoid receptor activation in the kidney tissue and the subsequent Rho-kinase stimulation are likely to participate in the development of obesity-associated nephropathy without elevation in serum aldosterone levels.
- 20 December 2011
- Published byย Springer Natureย inย International Journal of Obesity
- Vol.ย 36 ย (8) , 1062-1071
Open AccessRole of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury
We examined whether aldosterone/Rho/Rho-kinase pathway contributed to obesity-associated nephropathy. C57BL/6J mice were fed a high fat or low fat diet, and mice on a high fat diet were treated with a mineralocorticoid receptor antagonist, eplerenone. The mice on a high fat diet not only developed obesity, but also manifested renal histological changes, including glomerular hypercellularity and increased mesangial matrix, which paralleled the increase in albuminuria. Furthermore, enhanced Rho-kinase activity was noted in kidneys from high fat diet-fed mice, as well as increased expressions of inflammatory chemokines. All of these changes were attenuated by eplerenone. In high fat diet-fed mice, mineralocorticoid receptor protein levels in the nuclear fraction and SGK1, an effector of aldosterone, were upregulated in kidneys, although serum aldosterone levels were unaltered. Furthermore, aldosterone and 3ฮฒ-hydroxysteroid dehydrogenase in renal tissues were upregulated in high fat diet-fed mice. Finally, in cultured mesangial cells, stimulation with aldosterone enhanced Rho-kinase activity, and pre-incubation with eplerenone prevented the aldosterone-induced activation of Rho kinase. Excess fat intake causes obesity and renal injury in C57BL/6J mice, and these changes are mediated by an enhanced mineralocorticoid receptor/Rho/Rho-kinase pathway and inflammatory process. Mineralocorticoid receptor activation in the kidney tissue and the subsequent Rho-kinase stimulation are likely to participate in the development of obesity-associated nephropathy without elevation in serum aldosterone levels.
- Open Access
- 14 December 2011
- Published byย IntechOpen
Nephritis Associated with Ulcerative Colitis
Nephritis Associated with Ulcerative Colitis | InTechOpen, Published on: 2011-12-14. Authors: Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, et
- 14 December 2011
- Published byย IntechOpen
Open AccessNephritis Associated with Ulcerative Colitis
Nephritis Associated with Ulcerative Colitis | InTechOpen, Published on: 2011-12-14. Authors: Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, et